Achieve Life Sciences, Inc.

Finanzas de Achieve Life Sciences, Inc. (QUIT)

$6.060

-0.249 (-4.11%)Al cierre

Rentabilidad y márgenes de QUIT

Evaluating the bottom line, Achieve Life Sciences, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -104.23%, provide a clear picture of how effectively QUIT converts its operational activities into shareholder value.

Comparativa sectorial de QUIT

In the context of the broader market, QUIT competes directly with industry leaders such as IMMX and OLMA. With a market capitalization of $666.78M, it holds a leading position in the sector. When comparing efficiency, QUIT's gross margin of N/A stands against IMMX's N/A and OLMA's N/A. Such benchmarking helps identify whether Achieve Life Sciences, Inc. is trading at a premium or discount relative to its financial performance.

Desempeño financiero de Achieve Life Sciences, Inc.

BDJ has demonstrated robust financial performance with a 1-year change of +8.67% and a year-to-date change of +2.77%, reflecting positive momentum in its price.

Financials

FY2026Q3
0.00
Total Revenue
FY2026Q3
YoY:
+39.77%
-20.54M
Operating Profit
FY2026Q3
YoY:
-16.14%
-12.11M
Net Income after Tax
FY2026Q3
YoY:
-25.96%
-8.39M
Free Cash Flow

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar